Member Info for Bella6532

Zoom0001..afraid you clearly don't understand the French mentality towards buying non-French products...Macron is about to fight an election...if he puts his hat into the pile...and he certainly isn't about to let his prized health service buy LFTs from the UK if he can at all help it.

Selling into EU countries was never easy even before Brexit. They will and are using trade with the UK as bargaining tools as they try and finalise the Withdrawal Agreement terms such as N.Ireland and Fishing rights...none of which has gone away.

From March 2021...are we there yet????

'The requirement for the UK Target Product Profile (“TPP”) Rapid Breath Test requires 150 confirmed positive samples and 250 confirmed negative samples. Additional supervised breath test clinical trials from a larger group is expected to provide sufficient data to meet the desired and acceptable criteria in the TPP to roll out the COVID19 and other pathogen breath tests later this year.”

I have no problem with making a referral and the easiest solution should be thst all profit made as a result should be donated to the NHS. If the don't give up their gains then the tax office should apply a flat rate (very high estimate) and the person or company will have to prove otherwise.
What happened to 'in the national interest'...

https://www.thenational.scot/news/19719740.michelle-mone-among-10-tory-politicians-refer-firms-covid-vip-lane/

No more mention of their saliva test...yeah.
Yes Venn do have to get approval from Medusa19 before making changes but at least the site is somewhat clearer and dedicated to our LFT only. Who says shareholders can't effect change...I will send them a thank you note.

https://www.medusa19.com/en/delivery-policy/

BTW the name Medusa in itself tells me where the target market is...these boys understand branding...
Medusa19 = medical USA (made in the USA) covid 19
MeduFlow = medical you lateral flow

Branding is about hidden messaging...

Oops...

Your summary was great with all the Did you knows...
It might be worth sending to the guy at the Huff Post...plus target and send to key investigative journalists together with link to Neale Hanveys speech (video or written).
Just a thought if you want to take it further.

Come on Andy...how long is that piece of string?
We all know its coming soon...but the big question is...how soon is soon?
Still love your positive optimism hun...gives me a warm fuzzy feeling..xx

Yep...no history for a whole. Come on LSE get yer finger out...

'A parallel study is under review for publishing, which will further investigate comparative analysis versus a complete panel of lateral flow devices.'

Energyshares...one for you hun.
https://www.sciencedirect.com/science/article/pii/S1046592820301182

Energyshares...'Selling off Diagnostics would be a good move then they can focus on therapeutics.,'
Afraid I dont agree...don't underestimate the potential value of diagnostics as an income stream. The beauty of affimers is they allow for fast, accurate, low cost development for use in a very widespread marketplace. It would be foolish to give this up at this early stage especially with therapeutic costs growing hugely going forward if Avacta want to bring more products forward to trial.
Entering a market like the US on the therapeutics side is going to be very expensive...

Energyshares..if a deal/merger is being brokered it would certainly explain actions and lack of over recent months...

Hypermartin...It's been there since the announcement.

Yesyerday the only product they had in the Product section was their saliva test. The only product in there now is MeduFlow which is great but the front page is still unchanged.
Based on my exchanges with Venn, they seem to be the ones who are confused and are not 'getting it'...

Assme they will be calling off orders from the National Framework...

'We are proud to announce that Medusa 19 has been approved by the NHS Microbiology Framework Lot 1 for Goods and Services, for the supply of SARS-CoV-2 Lateral Flow Tests throughout the UK.

Medusa 19 are one of multiple selected suppliers to this Framework Contract which will run for the next 4 years and has a value of up to £3 Billion.

This Framework Contract allows the provision to all UK Government Departments and Trusts across England, Scotland, Northern Ireland and Wales subject to access agreement signature and Schedule 6 pricing, to supply the Rapid Saliva Protein Test (RSPT) and Avacta’s professional use AffiDx SARS-CoV-2 Antigen Lateral Flow Tests.

The Medusa tests detailed above and other parties lateral flow tests are now available for purchase by various government departments subject to their demand requirements. '

Personally I believe the LFT side of the business is extremely important for two reasons...
1. Financial...it should be a huge income generator with little expenditure/receivable burden.

2. It will put Affimers on the map...lock stock and globally as a new tech that does what it says on the tin. This is the most important part of all this for me. Affimers will be seen as a true alternative not a theoretical one.

Distributor deals have been done but we have no concrete confirmation as to what the sales levels are to date. Like everyone here, I hope they are flying out of the door right now with sales and demand beating expectations, but without confirmation we are still in the dark.

04-Jan-22 17:35:12 117.85 5,000 Unknown* 114.00 117.00 5,893 O
04-Jan-22 17:35:12 117.85 5,000 Unknown* 114.00 117.00 5,893 O
04-Jan-22 17:10:33 119.00 118,801 Unknown* 114.00 117.00 141.37k O
04-Jan-22 17:03:45 119.00 105,660 Unknown* 114.00 117.00 125.74k O
04-Jan-22 16:35:14 119.00 105,708 Buy* 114.00 117.00 125.79k UT

Neutronic...The Front Page is the main issue...it starts with MeduFlow only, then under National Framework it mentions 'Rapid Saliva Protein Test (RSPT) and Avacta’s professional use AffiDx SARS-CoV-2 Antigen Lateral Flow Tests' (note the plural tests). So how many tests are they able to offer...1, 2, 3 or more???
Then we have the Saturn Pass section which in the mobile phone pic just states Type: Medusa 19.
Then it immediately goes onto say HOW DOES IT WORK (note the word it)...and then it gives all the info for the Rapid Saliva Protein Test only...
Now if you just scroll from top to bottom quickly you see MeduFlow at the top and then scroll down to see how it works and are lead to believe it's a saliva test...!!!!!!
It's a mess...it's confusing...it's misleading...it's wrong...

Timster...I agree, and my Emails were sent to all three companies, however, only Venn responded today.